Johnson & Johnson’s Pharma Business Fuels Sales Growth
Wall Street Journal -

Johnson & Johnson’s pharmaceuticals business helped drive sales growth at the company for the latest quarter but the health-products giant’s U.S. consumer business continued to struggle.

Loading...

Related Articles